117
Views
3
CrossRef citations to date
0
Altmetric
Original Research

A Novel Mutation Of The EMD Gene In A Family With Cardiac Conduction Abnormalities And A High Incidence Of Sudden Cardiac Death

, ORCID Icon, , , , , , & show all
Pages 319-327 | Published online: 31 Oct 2019

References

  • Emery AE, Dreifuss FE. Unusual type of benign x-linked muscular dystrophy. J Neurol Neurosurg Psychiatry. 1966;29(4):338–342. doi:10.1136/jnnp.29.4.3385969090
  • Dubowitz V, editor. Muscle disorders in childhood 2nd ed. London: W.B. Saunders; 1995.
  • Emery AE. Emery-Dreifuss muscular dystrophy - a 40 year retrospective. Neuromuscul Disord. 2000;10(4–5):228–232.10838246
  • Meinke P, Schneiderat P, Srsen V, et al. Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery–Dreifuss muscular dystrophy. Neuromuscular Disord. 2015;25(2):127–136. doi:10.1016/j.nmd.2014.09.012
  • Bione S, Maestrini E, Rivella S, et al. Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy. Nat Genet. 1994;8(4):323–327. doi:10.1038/ng1294-3237894480
  • Manilal S, Nguyen TM, Sewry CA, Morris GE. The Emery-Dreifuss muscular dystrophy protein, emerin, is a nuclear membrane protein. Hum Mol Genet. 1996;5(6):801–808. doi:10.1093/hmg/5.6.8018776595
  • Ho CY, Jaalouk DE, Vartiainen MK, Lamin LJ. A/C and emerin regulate MKL1–SRF activity by modulating actin dynamics. Nature. 2013;497(7450):507–511. doi:10.1038/nature1210523644458
  • Muchir A, Worman HJ. Emery-Dreifuss muscular dystrophy. Curr Neurol Neurosci Rep. 2007;7(1):78–83.17217858
  • Koch AJ, Holaska JM. Emerin in health and disease. Semin Cell Dev Biol. 2014;29:95–106. doi:10.1016/j.semcdb.2013.12.00824365856
  • Madej-Pilarczyk A, Kochanski A. Emery-Dreifuss muscular dystrophy: the most recognizable laminopathy. Folia Neuropathol. 2016;54(1):1–8. doi:10.5114/fn.2016.5891027179216
  • Mondal K, Shetty AC, Patel V, Cutler DJ, Zwick ME. Targeted sequencing of the human X chromosome exome. Genomics. 2011;98(4):260–265. doi:10.1016/j.ygeno.2011.04.00421524701
  • Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–424. doi:10.1038/gim.2015.3025741868
  • Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009;132(Pt 11):3175–3186. doi:10.1093/brain/awp23619767415
  • Sakata K. High incidence of sudden cardiac death with conduction disturbances and atrial cardiomyopathy caused by a nonsense mutation in the STA gene. Circulation. 2005;111(25):3352–3358. doi:10.1161/CIRCULATIONAHA.104.52718415967842
  • Karst ML, Herron KJ, Olson TM. X-Linked nonsyndromic sinus node dysfunction and atrial fibrillation caused by Emerin mutation. J Cardiovasc Electr. 2008;19(5):510–515. doi:10.1111/j.1540-8167.2007.01081.x
  • Zhang M, Chen J, Si D, et al. Whole exome sequencing identifies a novel EMD mutation in a Chinese family with dilated cardiomyopathy. BMC Med Genet. 2014;15:77. doi:10.1186/1471-2350-15-7724997722
  • Chen W, Huo J, Ma A, Bai L, Liu P. A novel mutation of the LMNA gene in a family with dilated cardiomyopathy, conduction system disease, and sudden cardiac death of young females. Mol Cell Biochem. 2013;382(1–2):307–311. doi:10.1007/s11010-013-1734-323793583
  • Finsterer J, Stollberger C, Maeztu C. Sudden cardiac death in neuromuscular disorders. Int J Cardiol. 2016;203:508–515. doi:10.1016/j.ijcard.2015.10.17626551884
  • Russo V, Nigro G. ICD role in preventing sudden cardiac death in Emery-Dreifuss muscular dystrophy with preserved myocardial function: 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2015;17(2):337. doi:10.1093/europace/euu14624948592
  • Priori SG, Blomstrom-Lundqvist C, Mazzanti A, et al. ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC). Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2015;36(41):2793–2867.26320108
  • van Berlo JH, de Voogt WG, van der Kooi AJ, et al. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl). 2005;83(1):79–83. doi:10.1007/s00109-004-0589-115551023
  • Meune C, Van Berlo JH, Anselme F, Bonne G, Pinto YM, Duboc D. Primary prevention of sudden death in patients with lamin A/C gene mutations. N Engl J Med. 2006;354(2):209–210. doi:10.1056/NEJMc052632
  • van Rijsingen IA, Arbustini E, Elliott PM, et al. Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 2012;59(5):493–500. doi:10.1016/j.jacc.2011.08.07822281253
  • Fishbein MC, Siegel RJ, Thompson CE, Hopkins LC. Sudden death of a carrier of X-linked Emery-Dreifuss muscular dystrophy. Ann Intern Med. 1993;119(9):900–905. doi:10.7326/0003-4819-119-9-199311010-000068215002
  • Rakovec P, Zidar J, Sinkovec M, Zupan I, Brecelj A. Cardiac involvement in Emery-Dreifuss muscular dystrophy: role of a diagnostic pacemaker. Pacing Clin Electrophysiol. 1995;18(9 Pt 1):1721–1724. doi:10.1111/j.1540-8159.1995.tb06996.x7491318
  • Ishikawa K, Mimuro M, Tanaka T. Ventricular arrhythmia in X-linked Emery-Dreifuss muscular dystrophy: a lesson from an autopsy case. Intern Med. 2011;50(5):459–462. doi:10.2169/internalmedicine.50.459821372459
  • Straus SM, Bleumink GS, Dieleman JP, van der Lei J, Stricker BHC, Sturkenboom MCJM. The incidence of sudden cardiac death in the general population. J Clin Epidemiol. 2004;57(1):98–102. doi:10.1016/S0895-4356(03)00210-515019016
  • Bezzina CR, Lahrouchi N, Priori SG. Genetics of sudden cardiac death. Circ Res. 2015;116(12):1919–1936. doi:10.1161/CIRCRESAHA.116.30403026044248
  • Iio C, Ogimoto A, Nagai T, et al. Association between genetic variation in the SCN10A gene and cardiac conduction abnormalities in patients with hypertrophic cardiomyopathy. Int Heart J. 2015;56(4):421–427. doi:10.1536/ihj.14-41126104176
  • Tzimas I, Zingraf JC, Bajanowski T, Poetsch M. The role of known variants of KCNQ1, KCNH2, KCNE1, SCN5A, and NOS1AP in water-related deaths. Int J Legal Med. 2016;130(6):1575–1579. doi:10.1007/s00414-016-1424-227460199
  • Hertz CL, Christiansen SL, Larsen MK, et al. Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases. Eur J Hum Genet. 2016;24(6):817–822. doi:10.1038/ejhg.2015.19826350513
  • Christiansen SL, Hertz CL, Ferrero-Miliani L, et al. Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting. Eur J Hum Genet. 2016. doi:10.1038/ejhg.2016.118
  • Ackerman M, Atkins DL, Triedman JK. Sudden Cardiac Death in the Young. Circulation. 2016;133(10):1006–1026. doi:10.1161/CIRCULATIONAHA.115.02025426951821
  • Miles CJ, Behr ER. The role of genetic testing in unexplained sudden death. Transl Res. 2016;168:59–73. doi:10.1016/j.trsl.2015.06.00726143861